Med Life S.A. (BVB:M)
| Market Cap | 5.84B +36.8% |
| Revenue (ttm) | 3.34B +12.1% |
| Net Income | -13.97M |
| EPS | -0.03 |
| Shares Out | 530.82M |
| PE Ratio | n/a |
| Forward PE | 50.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 455,633 |
| Open | 10.52 |
| Previous Close | 10.66 |
| Day's Range | 10.40 - 10.96 |
| 52-Week Range | 7.38 - 14.46 |
| Beta | 0.42 |
| Analysts | Hold |
| Price Target | 10.67 (+0.66%) |
| Earnings Date | Aug 28, 2026 |
About Med Life
Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecul... [Read more]
Financial Performance
In 2025, Med Life's revenue was 3.17 billion, an increase of 16.86% compared to the previous year's 2.72 billion. Earnings were 11.27 million, a decrease of -55.00%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for M stock is "Hold." The 12-month stock price target is lei 10.67, which is an increase of 0.66% from the latest price.
News
Med Life Earnings Call Transcript: Q2 2026
Pro forma sales grew 11% year-over-year to RON 1.7 billion, with EBITDA margin improving to 16.4% and strong cash generation. Despite FX losses and some EBITDA-negative new hospitals, management remains confident in meeting full-year targets, focusing on organic growth, efficiency, and selective M&A.
Med Life Quarterly report: Q2 2026
Med Life has published its Q2 2026 quarterly earnings report on August 28, 2026.
Med Life Earnings release: Q2 2026
Med Life released its Q2 2026 earnings on August 28, 2026, summarizing the period's financial results.
Med Life Slides: Q2 2026
Med Life has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 28, 2026.
Med Life Earnings Call Transcript: Q1 2026
Q1 2026 saw 10% revenue growth and a 90% rise in net profit, driven by strong demand and expansion in clinics, hospitals, and labs. Margin improvement is expected through the year, with a focus on digitalization and personalized medicine.
Med Life Quarterly report: Q1 2026
Med Life has published its Q1 2026 quarterly earnings report on May 29, 2026.
Med Life Slides: Q1 2026
Med Life has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 29, 2026.
Med Life Quarterly report: Q4 2025
Med Life has published its Q4 2025 quarterly earnings report on February 27, 2026.
Med Life Slides: Q4 2025
Med Life has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Med Life Earnings Call Transcript: Q3 2025
Turnover grew 19.5% to RON 2.36 billion in the first nine months, with hospitals and clinics leading growth. EBITDA rose 20.4%, but net profit dropped 88% due to FX losses. Investments focused on new facilities, AI, and genetic testing, while debt and CapEx were closely managed.
Med Life Quarterly report: Q3 2025
Med Life has published its Q3 2025 quarterly earnings report on November 14, 2025.
Med Life Slides: Q3 2025
Med Life has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 14, 2025.